Alexion Pharmaceuticals Acquires Enobia Pharma for $1,080,000,000

  • Feed Type
  • Date
    12/29/2011
  • Company Name
    Enobia Pharma
  • Mailing Address
    55 Cambridge Parkway Cambridge, MA 02142
  • Company Description
    Enobia Pharma is a developer of enzyme replacement therapies for the treatment of serious bone diseases.
  • Website
    http://www.enobia.com
  • Transaction Type
    M&A
  • Transaction Amount
    $1,080,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Alexion has agreed to pay $610 million in cash upon consummation of the transaction, and up to $470 million in cash to be paid upon achievement of various regulatory and sales milestones. Alexion is not issuing equity in connection with the acquisition.

By posting a comment, you agree to our terms and conditions.